Guru Ownership Trend
Guru Analysis for Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $7.36 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $582,603.2 net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 68.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Eton Pharmaceuticals, Inc. (ETON)
Major holders include Renaissance Technologies (RenTech) ($1.89 M), Steven Cohen ($1.63 M), Jefferies Group ($1.23 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 147,227 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $582,603.2, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ETON. The total reported sell value was $4.02 M.
Yes, 3 managers opened new positions in ETON, and 0 increased their existing holdings. The total reported buy value was $3.44 M.